Skip to content

Arcturus Therapeutics Holdings Inc.

ARCT· NasdaqCore metricsCIK 1768224

Pharmaceutical preparations552 peers

Last sale
Nov 6, 2026 · +10.86%
Market cap
$298.75M
28.82M shares
Filings
418
$18.30M
Q3 2026−46.1% FY25 yoy
-$7.41M
Q3 2026N/M FY25 yoy
-$9.19M
Q3 2026N/M FY25 yoy
-$46.31M
Q3 2026derivedN/M FY25 yoy
-$0.26
Q3 2026N/M FY25 yoy
$184.82M
Q3 2026−2.6% FY25 yoy
$298.75M
—
9.8×
1.8×
-20.90%
—

Twelve months to Sep 30, 2026 · derived

Price

$10.37+19.97%+$1.72past year
Nov 6, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$82.03MFY 2025
$206.00M0FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$82,031,000reported
FY 20242024-12-31$152,310,000reported
FY 20232023-12-31$166,799,000reported
FY 20222022-12-31$205,999,000reported
FY 20212021-12-31$12,359,000reported
FY 20202020-12-31$9,539,000reported
FY 20192019-12-31$20,789,000reported
FY 20182018-12-31$15,753,000reported

Segments

Products
Revenue by Products, FY2021 to FY2025FY2021Collaboration Revenue · FY2021 · $12.36MFY2022Collaboration Revenue · FY2022 · $205.76MGrant Revenue · FY2022 · $244.00KFY2023Collaboration Revenue · FY2023 · $157.75MGrant Revenue · FY2023 · $9.05MFY2024Collaboration Revenue · FY2024 · $138.39MGrant Revenue · FY2024 · $13.92MFY2025Collaboration Revenue · FY2025 · $67.22MGrant Revenue · FY2025 · $14.81M
LineFY2025ShareChange
Collaboration Revenue$67.22M82%−51.4%
Grant Revenue$14.81M18%+6.4%
Total$82.03M

From the 10-K filed Mar 3, 2026ARCT

Pharmaceutical preparations

Arcturus Therapeutics Holdings Inc. is the 108th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Arcturus Therapeutics Holdings Inc. · CIK 1768224 · Engraved from SEC EDGAR